Inhak Choi

2.9k total citations
66 papers, 2.1k citations indexed

About

Inhak Choi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Inhak Choi has authored 66 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 19 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Inhak Choi's work include Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (13 papers). Inhak Choi is often cited by papers focused on Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (16 papers) and T-cell and B-cell Immunology (13 papers). Inhak Choi collaborates with scholars based in South Korea, United States and Ethiopia. Inhak Choi's co-authors include Su‐Kil Seo, Il‐Whan Choi, Sae-Gwang Park, Yung Hyun Choi, Soo-Woong Lee, Keun‐Ok Jung, Won‐Kyo Jung, Sung Su Yea, Young‐Don Joo and Lieping Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Analytical Chemistry.

In The Last Decade

Inhak Choi

64 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inhak Choi South Korea 28 866 569 538 165 163 66 2.1k
Su‐Kil Seo South Korea 24 489 0.6× 191 0.3× 600 1.1× 185 1.1× 51 0.3× 64 1.8k
Liang Ye China 24 811 0.9× 353 0.6× 647 1.2× 61 0.4× 61 0.4× 77 2.4k
Xiaoyi Hu China 17 565 0.7× 569 1.0× 1.0k 1.9× 32 0.2× 69 0.4× 31 2.5k
Seung‐Hoon Yang South Korea 20 733 0.8× 138 0.2× 1.1k 2.1× 73 0.4× 80 0.5× 50 2.5k
Yeong-Min Park South Korea 24 771 0.9× 557 1.0× 828 1.5× 42 0.3× 158 1.0× 44 2.0k
Parviz Kokhaei Iran 27 697 0.8× 592 1.0× 987 1.8× 20 0.1× 71 0.4× 120 2.3k
Peter Chang-Whan Lee South Korea 26 339 0.4× 258 0.5× 1.0k 1.9× 135 0.8× 187 1.1× 79 1.9k
Olivier Peulen Belgium 28 233 0.3× 335 0.6× 1.2k 2.3× 200 1.2× 125 0.8× 79 2.3k
Monireh Mohsenzadegan Iran 20 528 0.6× 359 0.6× 631 1.2× 24 0.1× 59 0.4× 56 1.8k
Jie Zhou China 34 1.4k 1.6× 448 0.8× 1.2k 2.2× 20 0.1× 110 0.7× 135 3.3k

Countries citing papers authored by Inhak Choi

Since Specialization
Citations

This map shows the geographic impact of Inhak Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inhak Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inhak Choi more than expected).

Fields of papers citing papers by Inhak Choi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inhak Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inhak Choi. The network helps show where Inhak Choi may publish in the future.

Co-authorship network of co-authors of Inhak Choi

This figure shows the co-authorship network connecting the top 25 collaborators of Inhak Choi. A scholar is included among the top collaborators of Inhak Choi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inhak Choi. Inhak Choi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choi, Inhak, et al.. (2022). VSTM5 is a novel immune checkpoint that promotes oral tolerance of cell-mediated and antibody responses. Biochemical and Biophysical Research Communications. 635. 283–290. 1 indexed citations
2.
Lee, Chan Ho, Soo Jin Jung, Ha Young Park, et al.. (2021). Expression of VISTA on tumor-infiltrating immune cells correlated with short intravesical recurrence in non-muscle-invasive bladder cancer. Cancer Immunology Immunotherapy. 70(11). 3113–3122. 20 indexed citations
3.
Kwon, Minsuk, Hoyoung Lee, Hyunsoo Cho, et al.. (2020). PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors. Clinical Cancer Research. 26(7). 1644–1655. 34 indexed citations
4.
Choi, Inhak, et al.. (2017). V‐set and Ig domain‐containing 4 (VSIG4)‐expressing hepatic F4/80+ cells regulate oral antigen‐specific responses in mouse. European Journal of Immunology. 48(4). 632–643. 5 indexed citations
5.
Ishibashi, Mariko, Hideto Tamura, Namiko Okuyama, et al.. (2016). Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1. Cancer Immunology Research. 4(9). 779–788. 78 indexed citations
6.
Jung, Keun‐Ok, Su‐Kil Seo, & Inhak Choi. (2015). Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response. Immunology Letters. 165(2). 78–83. 23 indexed citations
7.
Hong, Sungyoul, Keun‐Ok Jung, Su‐Jun Lee, et al.. (2013). Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma. Immunology Letters. 156(1-2). 132–139. 17 indexed citations
8.
Choi, Inhak, et al.. (2012). A high-speed, high-performance on-chip integrated reverse transcription (RT)-microchip. Biomedical Microdevices. 15(1). 9–15. 4 indexed citations
9.
Joo, Young‐Don, Won-Sik Lee, Hye Ran Kim, et al.. (2012). G-CSF-treated donor CD4+ T cells attenuate acute GVHD through a reduction in Th17 cell differentiation. Cytokine. 60(1). 277–283. 8 indexed citations
10.
Choi, Inhak, et al.. (2011). Enhancement of DC vaccine efficacy via regulation of interleukin-6 receptor signaling (66.2). The Journal of Immunology. 186(1_Supplement). 66.2–66.2. 1 indexed citations
11.
Jung, Won‐Kyo, Da Young Lee, Cheol Park, et al.. (2010). Cilostazol is anti‐inflammatory in BV2 microglial cells by inactivating nuclear factor‐kappaB and inhibiting mitogen‐activated protein kinases. British Journal of Pharmacology. 159(6). 1274–1285. 90 indexed citations
12.
13.
Jung, Won‐Kyo, Inhak Choi, Sangtaek Oh, et al.. (2008). Anti-asthmatic effect of marine red alga (Laurencia undulata) polyphenolic extracts in a murine model of asthma. Food and Chemical Toxicology. 47(2). 293–297. 61 indexed citations
14.
Jung, Won‐Kyo, Inhak Choi, Da-Young Lee, et al.. (2008). Caffeic acid phenethyl ester protects mice from lethal endotoxin shock and inhibits lipopolysaccharide-induced cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 macrophages via the p38/ERK and NF-κB pathways. The International Journal of Biochemistry & Cell Biology. 40(11). 2572–2582. 106 indexed citations
15.
Jung, Won‐Kyo, Yung Hyun Choi, Sung Su Yea, et al.. (2008). Caffeic acid phenethyl ester attenuates allergic airway inflammation and hyperresponsiveness in murine model of ovalbumin-induced asthma. Life Sciences. 82(13-14). 797–805. 79 indexed citations
16.
Kim, Yeong Seok, Ga Bin Park, Hyun-Kyung Lee, et al.. (2008). Cross-Linking of B7-H1 on EBV-Transformed B Cells Induces Apoptosis through Reactive Oxygen Species Production, JNK Signaling Activation, and fasL Expression. The Journal of Immunology. 181(9). 6158–6169. 33 indexed citations
17.
Kim, Gi‐Young, Moo‐Yeol Lee, Hee-Jeong Lee, et al.. (2005). Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells. International Immunopharmacology. 5(10). 1523–1532. 42 indexed citations
18.
19.
Choi, Inhak, et al.. (1998). Generation of Human Fab Monoclonal Antibodies Against preS 1 of Hepatitis B Virus Using Repertoire Cloning. Hybridoma. 17(6). 535–540. 8 indexed citations
20.
Chung, Junho, et al.. (1998). Expression, Characterization and Chain Shuffling of an Anti-HBsAg Phage Antibody. Open Access System for Information Sharing (Pohang University of Science and Technology). 33(3). 307–316. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Su‐Kil Seo Breakdown of academic impact, for papers by Liang Ye Breakdown of academic impact, for papers by Xiaoyi Hu Breakdown of academic impact, for papers by Seung‐Hoon Yang Breakdown of academic impact, for papers by Yeong-Min Park Breakdown of academic impact, for papers by Parviz Kokhaei Breakdown of academic impact, for papers by Peter Chang-Whan Lee Breakdown of academic impact, for papers by Olivier Peulen Breakdown of academic impact, for papers by Monireh Mohsenzadegan Breakdown of academic impact, for papers by Jie Zhou
Rankless by CCL
2026